Event details
Transforming Natural Product Discovery into a Process of Precision Medicine
In this seminar I will describe methods to assess the activity of secondary metabolites within metabolomes prior to their isolation. In particular, I will discuss the development and application of new methods to perform bioactive small molecule discovery using patient-derived cell preparations containing both tumor and functional immune cells from multiple patients. These methods bypass the traditional lead discovery processes using immortalized cell lines and aim to provide lead compounds for chemo and immuno-oncology campaigns with an unprecedented depth of preclinical characterization.
University programs and activities are open to all eligible participants without regard to identity or other protected characteristics. Sponsorship of an event does not constitute institutional endorsement of external speakers or views presented.
View physical accessibility information for campus buildings and find accessible routes using the Princeton Campus Map app.